Related Experiment Videos
Craviten effect on the metabolism of stored platelets
Insights
Craviten preserves platelet energy levels and metabolic enzymes, inhibiting spontaneous aggregation and increasing nucleotide release. This study shows Craviten enhances platelet function and stability.
Area of Science:
- Biochemistry
- Hematology
- Pharmacology
Background:
- Platelet metabolic activity and function are crucial for hemostasis.
- Stored platelets can experience a decline in energy compounds and increased aggregation.
- Understanding agents that can preserve platelet function during storage is important.
Purpose of the Study:
- To investigate the effects of Craviten on platelet metabolic activity and function.
- To evaluate Craviten's impact on platelet energy levels, enzyme activity, and aggregation.
- To determine Craviten's influence on platelet nucleotide release and cyclic AMP (c-AMP) levels.
Main Methods:
- Platelets were incubated with Craviten using two different methods (pre-storage and post-storage).
- Assessed levels of adenosine triphosphate (ATP) and adenosine diphosphate (ADP).
- Measured hexokinase and pyruvate kinase activity, thrombin-induced nucleotide release, spontaneous aggregation, and cyclic AMP (c-AMP).
Main Results:
- Craviten prevented the decrease in ATP levels in stored platelets.
- It increased the activity of hexokinase and pyruvate kinase.
- Craviten inhibited spontaneous platelet aggregation and increased nucleotide release, while also raising c-AMP levels.
Conclusions:
- Craviten demonstrates a protective effect on platelet energy metabolism.
- The drug enhances platelet function by preserving enzyme activity and improving the release reaction.
- Craviten may be beneficial in maintaining platelet viability and function, particularly for stored platelets.
Abstract:
Craviten effect on platelets suspended in their own plasma was investigated by two methods of incubation with the drug: the fresh platelets were incubated for 18 h at 4 degrees C with Craviten added to plasma and platelets stored for 18 h at 4 degrees C without Craviten were incubated with Craviten at 37 degrees C for 1 h. For evaluation of the metabolic activity and function of the platelets, the levels of high-energy compounds ATP and ADP, the activity of hexokinase and pyruvate kinase and the amount of adenyl nucleotides released by the platelets after thrombin addition were measured, and the spontaneous aggregation of platelets and c-AMP were determined. The experiments demonstrated that Craviten prevented the fall of ATP level of the stored platelets, raised the activity of hexokinase and pyruvate kinase in the platelets, increased the amount of nucleotides released by the platelets in the release reaction. Craviten inhibited also increased spontaneous aggregation of stored platelets and raised c-AMP level.